TrialFrontiers in cellular and infection microbiology2023

A phase I study to assess safety, pharmacokinetics, and pharmacodynamics of a vaginal insert containing tenofovir alafenamide and elvitegravir.

Andrea R Thurman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.